Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Drug Metabolism and Personalized Therapy

Official journal of the European Society of Pharmacogenomics and Personalised Therapy

Editor-in-Chief: Llerena, Adrián

Editorial Board Member: Chen, Bing / Dahl, Marja-Liisa / Devinsky, Ferdinand / Hirata, Rosario / Hubacek, Jaroslav A. / Ingelman-Sundberg, Magnus / Maitland-van der Zee, Anke-Hilse / Manolopoulos, Vangelis G. / Marc, Janja / Melichar, Bohuslav / Meyer, Urs A. / Nair, Sujit / Nofziger, Charity / Peiro, Ana / Sadee, Wolfgang / Salazar, Luis A. / Simmaco, Maurizio / Turpeinen, Miia / Schaik, Ron / Shin, Jae-Gook / Visvikis-Siest, Sophie / Zanger, Ulrich M.

4 Issues per year


CiteScore 2016: 1.40

SCImago Journal Rank (SJR) 2016: 0.413
Source Normalized Impact per Paper (SNIP) 2016: 0.537

Online
ISSN
2363-8915
See all formats and pricing
More options …
Volume 27, Issue 3 (Aug 2012)

Issues

CYP2E1 potentiates toxicity in obesity and after chronic ethanol treatment

Arthur I. Cederbaum
  • Corresponding author
  • Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, Box 1603, One Gustave L Levy Place, New York, NY 10029, USA
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2012-07-27 | DOI: https://doi.org/10.1515/dmdi-2012-0014

Abstract:

CYP2E1 activates several hepatotoxins and contributes to alcoholic liver damage. In this report, we review our studies on whether induction of CYP2E1 can potentiate liver injury in obesity. Acetone- or pyrazole-induced severe liver injury in obese mice as compared to obese controls and lean mice. Severe liver injury was associated with elevated oxidative and nitrosative stress and could be blunted by inhibitors of CYP2E1 and inducible nitric oxide synthase (iNOS). S-Adenosyl-L-methionine (SAM) lowered the elevated oxidative and nitrosative stress, steatosis, liver injury and mitochondrial dysfunction in the pyrazole-treated obese mice. The protection by SAM may have therapeutic applications against metabolic complications caused by obesity. The role of CYP2E1 in chronic ethanol-induced liver injury was studied using wild-type (WT) mice, CYP2E1 knockout (KO) mice and humanized CYP2E1 knockin (KI) mice. Ethanol produced fatty liver and oxidant stress in WT mice; these effects were blunted in the CYP2E1 KO mice but restored in the CYP2E1 KI mice. Significant liver injury was produced in the ethanol-fed KI mice in association with elevated oxidant stress and levels of human CYP2E1. Collectively, these studies show that CYP2E1 contributes to ethanol-induced and obesity-induced oxidant stress and liver injury.

Keywords: CYP2E1; ethanol; obesity; oxidative stress; S-adenosyl methionine; steatosis

About the article

Corresponding author: Arthur I. Cederbaum, Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, Box 1603, One Gustave L Levy Place, New York, NY 10029, USA, Phone: +(212) 241-9352, Fax: +(212) 996-7214


Received: 2012-05-01

Accepted: 2012-07-02

Published Online: 2012-07-27

Published in Print: 2012-08-01


Citation Information: , ISSN (Online) 2191-0162, ISSN (Print) 0792-5077, DOI: https://doi.org/10.1515/dmdi-2012-0014.

Export Citation

©2012 by Walter de Gruyter Berlin Boston. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Mohamed A. Abdelmegeed, Youngshim Choi, Grzegorz Godlewski, Seung-Kwon Ha, Atrayee Banerjee, Sehwan Jang, and Byoung-Joon Song
Scientific Reports, 2017, Volume 7, Page 39764
[2]
Konstantinos C. Makris, Xanthi D. Andrianou, Pantelis Charisiadis, James B. Burch, Ratanesh K. Seth, Androniki Ioannou, Michael Picolos, Costas A. Christophi, and Saurabh Chatterjee
Environment International, 2016, Volume 92-93, Page 486
[3]
Lian-Yun Chen, Qin Chen, Yi-Feng Cheng, Huan-Huan Jin, De-Song Kong, Feng Zhang, Li Wu, Jiang-juan Shao, and Shi-Zhong Zheng
Biomedicine & Pharmacotherapy, 2016, Volume 79, Page 35
[4]
Varun Chandrashekaran, Suvarthi Das, Ratanesh Kumar Seth, Diptadip Dattaroy, Firas Alhasson, Gregory Michelotti, Mitzi Nagarkatti, Prakash Nagarkatti, Anna Mae Diehl, and Saurabh Chatterjee
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2016, Volume 1862, Number 1, Page 32
[5]
Patience O. Obih and Barry J. Potter
Pharmacology & Pharmacy, 2014, Volume 05, Number 13, Page 1202
[6]
N. Duale, I.-L. Steffensen, J. Andersen, A. Brevik, G. Brunborg, and B. Lindeman
Andrology, 2014, Volume 2, Number 2, Page 234
[7]
Samir Zakhari
Journal of Gastroenterology and Hepatology, 2013, Volume 28, Page 18
[8]
Hui Peng, Shang-Kui Xie, Mei-Jin Huang, and Dong-Lin Ren
Tumor Biology, 2013, Volume 34, Number 4, Page 2389

Comments (0)

Please log in or register to comment.
Log in